Okun Andrew 4
4 · PERKINELMER INC · Filed Apr 13, 2023
Insider Transaction Report
Form 4
Okun Andrew
VP & Chief Accounting Officer
Transactions
- Exercise/Conversion
NQ Stock Option (right to buy)
2023-04-11−318→ 1,357 totalExercise: $96.06Exp: 2027-01-30→ Common Stock (318 underlying) - Exercise/Conversion
NQ Stock Option (right to buy)
2023-04-12−701→ 656 totalExercise: $96.06Exp: 2027-01-30→ Common Stock (701 underlying) - Exercise/Conversion
Common Stock
2023-04-11$96.06/sh+318$30,547→ 10,431 total - Sale
Common Stock
2023-04-12$135.29/sh−3,146$425,622→ 6,135 total - Sale
Common Stock
2023-04-11$135.01/sh−1,851$249,904→ 8,580 total - Exercise/Conversion
Common Stock
2023-04-12$96.06/sh+701$67,338→ 9,281 total
Holdings
- 8(indirect: By 401(k))
Common Stock
Footnotes (4)
- [F1]The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by Mr. Okun on February 21, 2023.
- [F2]The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $135.00 to $135.05. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
- [F3]The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $135.00 to $135.93. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
- [F4]This option became exercisable in three equal annual installments beginning on January 30, 2021, which was the first anniversary of the date on which the option was granted.